4//SEC Filing
DiPalma Stephen J. 4
Accession 0001209191-21-033477
CIK 0001693011other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:18 PM ET
Size
5.7 KB
Accession
0001209191-21-033477
Insider Transaction Report
Form 4
DiPalma Stephen J.
Interim CFO
Transactions
- Award
Stock option (Right to Buy)
2021-05-17+15,000→ 15,000 totalExercise: $15.90Exp: 2031-05-16→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option was granted on May 17, 2021 and will vest as to 50% of the shares underlying the option on the date that is 180 days following the grant date and as to the remaining 50% of the shares underlying the option on the first anniversary of the grant date, provided Mr. DiPalma is providing services to the Company on such dates.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001426479
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:18 PM ET
- Size
- 5.7 KB